These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22017168)

  • 1. Osteopontin as a marker of weight loss in lung cancer.
    Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
    Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer.
    Derin D; Soydinç HO; Guney N; Tas F; Camlica H; Duranyildiz D; Yasasever V; Topuz E
    Lung Cancer; 2008 Feb; 59(2):240-5. PubMed ID: 17875341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.
    Takenaka M; Hanagiri T; Shinohara S; Yasuda M; Chikaishi Y; Oka S; Shimokawa H; Nagata Y; Nakagawa M; Uramoto H; So T; Yamada S; Tanaka F
    Clin Lung Cancer; 2013 May; 14(3):288-94. PubMed ID: 23122494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.
    Chang YS; Kim HJ; Chang J; Ahn CM; Kim SK; Kim SK
    Lung Cancer; 2007 Sep; 57(3):373-80. PubMed ID: 17513004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.
    Jamieson NB; Brown DJ; Michael Wallace A; McMillan DC
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):90-2. PubMed ID: 15242698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
    Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
    Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
    Huang F; Wang XL; Geng Y; Li MX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
    Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
    Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
    Kanoh Y; Abe T; Masuda N; Akahoshi T
    Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines and systemic inflammation in weight-losing lung cancer patients.
    Gulen ST; Karadag F; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
    Lung; 2012 Jun; 190(3):327-32. PubMed ID: 22246553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
    BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.
    Karapanagiotou EM; Polyzos A; Dilana KD; Gratsias I; Boura P; Gkiozos I; Syrigos KN
    Lung Cancer; 2009 Dec; 66(3):393-8. PubMed ID: 19282046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
    Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
    J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
    Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
    Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
    Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
    Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesfatin-1 in advanced lung cancer patients with weight loss.
    Cetinkaya H; Karagöz B; Bilgi O; Ozgün A; Tunçel T; Emirzeoğlu L; Top C; Kandemir EG
    Regul Pept; 2013 Feb; 181():1-3. PubMed ID: 23269222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.